"The results from the FDA audit are extremely positive and serve as a testament to the high quality standards that BioScreen sets for itself," said Ranil M. Fernando, executive vice president, BioScreen.
BioScreen's President, Bradford Rope added, "We are extremely pleased to share this news with our valued customers to indicate the robustness of our quality system."
BioScreen Testing Services is a contract testing laboratory servicing the needs of medical device, pharmaceutical and personal care industries. BioScreen specializes in performing analytical chemistry, human clinical trials, microbiological and toxicological studies for FDA regulated companies.
More info: BioScreen Testing Services, Torrance, CA USA; Tel: 310-214-0043; Website: www.bioscreen.com